Gradient Health
Healthcare and payments data require additional regulatory and contractual review
The 20% figure is the provider's own illustrative “typical” rate, not a guaranteed offer or an industry benchmark, and is not used as a valuation-model input.
Healthcare data requires additional regulatory and contractual review before any licensing discussion.
What the provider says it does
Gradient Health says data partners contribute existing medical data; it handles transfer, de-identification, curation and review, then distributes the data for approved AI-development projects and shares project revenue with the partner. Its data-partner page illustrates a “20% (typical revenue share for data partners)”, allocated by the partner's share of studies in a deal, and says future use generates additional revenue. Its FAQ says terms depend on data type, scale and usability. These are Gradient Health's own statements and have not been independently verified.
- Business model
- Company-data partnershipMedical-data partnership: partners supply existing data; Gradient Health says it de-identifies, curates and licenses it to AI developer customers and shares revenue.
- Seller intake
- Public data-partner inquiry at https://gradienthealth.io/data-partner
- Contracting party
- Not publicly stated
- Data focus
- Medical and clinical data
- Data types considered
- Medical imaging / radiologyElectronic health recordsPathology reportsClinical recordsImaging metadataLongitudinal patient records
- Intended uses
- Training
- Geography
- Buyer-facing material describes data sourced “from around the globe”; seller country eligibility is not publicly stated
- Stated handling & privacy
- Gradient Health says it de-identifies and curates partner data before distribution; the method and residual re-identification risk must be confirmed.
- Healthcare data is heavily regulated; the seller must confirm authority to share, patient privacy obligations and any required agreements before engaging.
- Retention, deletion, resale
- Not publicly stated
- Payment / licensing model
- Provider's data-partner page illustrates a typical 20% revenue share for data partners, allocated by share of studies in a deal, with additional revenue from future use. Its FAQ says terms depend on data type, scale and usability; the illustration is not a guaranteed offer.
- Exclusivity
- Not publicly stated
- Referral program
- Not publicly confirmed
Sources
- Gradient Health — Data partners (opens in new tab)Provider website · reviewed 2026-10-17
- Gradient Health — For AI developers (opens in new tab)Provider website · reviewed 2026-10-17